期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer 被引量:1
1
作者 Rebecca Carter Azadeh Cheraghchi-Bashi +11 位作者 Adam Westhorpe Sheng Yu Yasmin Shanneik Elena Seraia Djamila Ouaret Yasuhiro Inoue Catherine Koch Jenny Wilding Daniel Ebner Anderson J. Ryan Francesca M. Buffa Ricky A. Sharma 《Cancer Biology & Medicine》 SCIE CAS CSCD 2019年第2期234-246,共13页
Objective: Patients with BRAF-mutant colorectal cancer(CRC) have a poor prognosis. Molecular status is not currently used to select which drug to use in combination with radiotherapy. Our aim was to identify drugs tha... Objective: Patients with BRAF-mutant colorectal cancer(CRC) have a poor prognosis. Molecular status is not currently used to select which drug to use in combination with radiotherapy. Our aim was to identify drugs that radiosensitise CRC cells with known BRAF status.Methods: We screened 298 oncological drugs with and without ionising radiation in colorectal cancer cells isogenic for BRAF. Hits from rank product analysis were validated in a 16-cell line panel of human CRC cell lines, using clonogenic survival assays and xenograft models in vivo.Results: Most consistently identified hits were drugs targeting cell growth/proliferation or DNA damage repair. The most effective class of drugs that radiosensitised wild-type and mutant cell lines was PARP inhibitors. In clonogenic survival assays, talazoparib produced a radiation enhancement ratio of 1.9 in DLD1(BRAF-wildtype) cells and 1.8 in RKO(BRAF V600 E) cells. In DLD1 xenografts, talazoparib significantly increased the inhibitory effect of radiation on tumour growth(P ≤ 0.01).Conclusions: Our method for screening large drug libraries for radiosensitisation has identified PARP inhibitors as promising radiosensitisers of colorectal cancer cells with wild-type and mutant BRAF backgrounds. 展开更多
关键词 RADIOSENSITIZER COLORECTAL cancer PARP inhibitor radiotherapy
下载PDF
Swine waste as a source of natural products: A carotenoid antioxidant
2
作者 Lawrence B. Cahoon Christopher J. Halkides +6 位作者 Bongkeun Song C. Michael Williams George R. Dubay Alexandra Fries Johanna Farmer William Fridrich Charles Brookshire 《Agricultural Sciences》 2012年第6期806-815,共10页
Development of Environmentally Superior Technologies swine waste management has focused on extraction of products with relatively low unit values. Analyses of the bacterial composition of swine waste lagoon samples co... Development of Environmentally Superior Technologies swine waste management has focused on extraction of products with relatively low unit values. Analyses of the bacterial composition of swine waste lagoon samples confirmed the presence of several purple non-sulfur bacteria (PNSB) species known to produce a variety of carotenoids. We examined a carotenoid naturally abundant in North Carolina swine waste lagoons dominated by PNSB. Analytical methods including high performance liquid chromatography (HPLC), mass spectrometry, and nuclear magnetic resonance (NMR) confirmed the identity of the dominant carotenoid as spirilloxanthin, C42H60O2, with 13 conjugated double bonds. This structure confers antioxidant properties as good as those of carotenoids currently marketed as antioxidants. Visual estimates of the “redness” of swine waste lagoon liquids were highly correlated with carotenoid content. Spirilloxanthin concentrations in a lagoon with a strong PNSB bloom were approximately 0.5 grams·m-3. These results support further investigations into the potential for extracting commercially valuable natural products from swine waste lagoons. 展开更多
关键词 SWINE WASTE PURPLE Phototrophic BACTERIA Carotenoids Spirilloxanthin
下载PDF
Engineering a New Chloroplastic Photorespiratory Bypass to In crease Photosynthetic Efficiency and Productivity in Rice 被引量:44
3
作者 Bo-Ran Shen Li-Min Wang +9 位作者 Xiu-Ling Lin Zhen Yao Hua-Wei Xu Cheng-Hua Zhu Hai-Yan Teng Li-Li Cui E.-E. Liu Jian-Jun Zhang Zheng-Hui He Xin-Xiang Peng 《Molecular Plant》 SCIE CAS CSCD 2019年第2期199-214,共16页
Over the past few years, three photorespiratory bypasses have been introduced into plants, two of which led to observable in creases in photos yn thesis and biomass yield. However, most of the experiments were carried... Over the past few years, three photorespiratory bypasses have been introduced into plants, two of which led to observable in creases in photos yn thesis and biomass yield. However, most of the experiments were carried out using Arabidopsis under controlled environmental conditions, and the increases were only observed under low-light and short-day conditions. In this study, we designed a new photorespiratory bypass (called GOC bypass), characterized by no reducing equivalents being produced during a complete oxidation of glycolate into CO2 catalyzed by three rice-self-originating enzymes, i.e., glycolate oxidase, oxalate oxidase, and catalase. We successfully established this bypass in rice chloroplasts using a multi-gene assembly and transformation system. Transgenic rice plants carrying GOC bypass (GOC plants) showed significant increases in photosynthesis efficiency, biomass yield, and nitrogen content, as well as several other CO2-enriched phe no types under both greenhouse and field conditions .Grain yield of GOC plants varied depending on seeding season and was increased significantly in the spring. We further demonstrated that GOC plants had significant advantages under high-light conditions and that the improvements in GOC plants resulted primarily from a photosynthetic CO2-concentrating effect rather than from improved energy balance. Taken together, our results reveal that engineering a newly designed chloroplastic photorespiratory bypass could increase photosynthetic efficiency and yield of rice plants grown in field conditions, particularly under high light. 展开更多
关键词 photorespiratory BYPASS PHOTOSYNTHETIC EFFICIENCY PRODUCTIVITY RICE
原文传递
Genomic Shift in Population Dynamics of mcr-1-positive Escherichia coli in Human Carriage 被引量:1
4
作者 Yingbo Shen Rong Zhang +12 位作者 Dongyan Shao Lu Yang Jiayue Lu Congcong Liu Xueyang Wang Junyao Jiang Boxuan Wang Congming Wu Julian Parkhill Yang Wang Timothy R.Walsh George F.Gao Zhangqi Shen 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2022年第6期1168-1179,共12页
Emergence of the colistin resistance gene,mcr-1,has attracted worldwide attention.Despite the prevalence of mcr-1-positive Escherichia coli(MCRPEC)strains in human carriage showing a significant decrease between 2016 ... Emergence of the colistin resistance gene,mcr-1,has attracted worldwide attention.Despite the prevalence of mcr-1-positive Escherichia coli(MCRPEC)strains in human carriage showing a significant decrease between 2016 and 2019,genetic differences in MCRPEC strains remain largely unknown.We therefore conducted a comparative genomic study on MCRPEC strains from fecal samples of healthy human subjects in 2016 and 2019.We identified three major differences in MCRPEC strains between these two time points.First,the insertion sequence ISApl1 was often deleted and the percentage of mcr-1-carrying IncI2 plasmids was increased in MCRPEC strains in 2019.Second,the antibiotic resistance genes(ARGs),aac(3)-IVa and blaCTX-M-1,emerged and coexisted with mcr-1 in 2019.Third,MCRPEC strains in 2019 contained more virulence genes,resulting in an increased proportion of extraintestinal pathogenic E.coli(ExPEC)strains(36.1%)in MCRPEC strains in 2019 compared to that in 2016(10.5%),implying that these strains could occupy intestinal ecological niches by competing with other commensal bacteria.Our results suggest that despite the significant reduction in the prevalence of MCRPEC strains in humans from 2016 to 2019,MCRPEC exhibits increased resistance to other clinically important ARGs and contains more virulence genes,which may pose a potential public health threat. 展开更多
关键词 COLISTIN mcr-1 Escherichia coli GENOMICS Human
原文传递
A new osteogenic protein isolated from Dioscorea opposita Thunb accelerates bone defect healing through the mTOR signaling axis 被引量:2
5
作者 John Akrofi Kubi Augustine Suurinobah Brah +5 位作者 Kenneth Man Chee Cheung Yin Lau Lee Kai-Fai Lee Stephen Cho Wing Sze Wei Qiao Kelvin Wai-Kwok Yeung 《Bioactive Materials》 SCIE CSCD 2023年第9期429-446,共18页
Delayed bone defect repairs lead to severe health and socioeconomic impacts on patients. Hence, there are increasing demands for medical interventions to promote bone defect healing. Recombinant proteins such as BMP-2... Delayed bone defect repairs lead to severe health and socioeconomic impacts on patients. Hence, there are increasing demands for medical interventions to promote bone defect healing. Recombinant proteins such as BMP-2 have been recognized as one of the powerful osteogenic substances that promote mesenchymal stem cells (MSCs) to osteoblast differentiation and are widely applied clinically for bone defect repairs. However, recent reports show that BMP-2 treatment has been associated with clinical adverse side effects such as ectopic bone formation, osteolysis and stimulation of inflammation. Here, we have identified one new osteogenic protein, named ‘HKUOT-S2’ protein, from Dioscorea opposita Thunb. Using the bone defect model, we have shown that the HKUOT-S2 protein can accelerate bone defect repair by activating the mTOR signaling axis of MSCs-derived osteoblasts and increasing osteoblastic biomineralization. The HKUOT-S2 protein can also modulate the transcriptomic changes of macrophages, stem cells, and osteoblasts, thereby enhancing the crosstalk between the polarized macrophages and MSCs-osteoblast differentiation to facilitate osteogenesis. Furthermore, this protein had no toxic effects in vivo. We have also identified HKUOT-S2 peptide sequence TKSSLPGQTK as a functional osteogenic unit that can promote osteoblast differentiation in vitro. The HKUOT-S2 protein with robust osteogenic activity could be a potential alternative osteoanabolic agent for promoting osteogenesis and bone defect repairs. We believe that the HKUOT-S2 protein may potentially be applied clinically as a new class of osteogenic agent for bone defect healing. 展开更多
关键词 Dioscorea spp protein Mesenchymal stem cells(MSCs) Osteoblast differentiation Bone mineral density(BMD) Bone defect repair mTOR signaling pathway
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部